Jason Valent
Multiple Myeloma Program Director · Cleveland Clinic Outpatient Center A - Austintown
Credentials: · · · · · ·
History
- Present
Multiple Myeloma · Cleveland Clinic Outpatient Center A - Austintown
- 2007–2010
- 1994–1998
Research
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
New England Journal of Medicine · 2021 · 562 citations
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2023 · 137 citations
The Lancet Haematology · 2021 · 112 citations
35 papers
33 papers
30 papers · 5 as a fellow
24 papers
20 papers
- SM
19 papers · 1 as a fellow
17 papers
15 papers · 12 as a fellow
Clinical trials
- 2023–2026
Principal investigator · Active not recruiting
Case Comprehensive Cancer Center
- 2014–2018
MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma
Principal investigator · Completed · Phase 1, Phase 2
Jason Valent